News Industry News Medtronic Drug-Filled Stent Shows Promising Initial Results Following First Implants October 12, 2015
News Industry News First-In-Man Study Examines Angiographic And Clinical Outcomes Of Newest Bioresorbable Magnesium Stent October 12, 2015
News Industry News Clinical Trial Demonstrates That A Bioresorbable Scaffold is Non-Inferior To A Drug-Eluting Stent In Chinese Patients With Coronary Artery Disease October 12, 2015
News Industry News ABSORB III: Clinical Trial Demonstrates That A Bioresorbable Scaffold Is Non-Inferior To A Drug-Eluting Stent In Patients With Coronary Artery Disease October 12, 2015
News Industry News Valtech's CE Mark-Approved Cardioband® for Transcatheter Mitral Valve Repair to Be Highlighted at the 2015 Transcatheter Cardiovascular Therapeutics Annual Meeting October 11, 2015
News Industry News Boston Scientific Announces Additional Investment And Right To Acquire MValve Technologies October 08, 2015
News Industry News Medtronic to Unveil New Clinical Data for its Innovative Portfolio of Interventional Technologies at TCT 2015 October 07, 2015
News Industry News Acutus Medical’s AcQMap™ High Resolution Imaging and Mapping System Provides High-Resolution Cardiac Mapping Combined with Exceptional Accuracy in Ultrasound Chamber Reconstruction in Patients with AF October 07, 2015
News Industry News QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch October 06, 2015
News Industry News MValve Technologies Implants First Human Catheter Based Mitral Valve Replacement System October 05, 2015
News Industry News Occlutech obtains European CE Approval for its novel mVSD Device September 30, 2015
News Industry News Early Patient Cases with Mitra-Spacer™ System presented at PCR London Valves 2015 September 21, 2015
News Industry News CeloNova Announces FDA Approval to Start a Randomized Trial for the COBRA PzF™ Coronary Stent System September 21, 2015
News Industry News Jardiance® (empagliflozin) is the only diabetes medication to show a significant reduction in both cardiovascular risk and cardiovascular death in a dedicated outcome trial September 18, 2015
News Industry News Portola Pharmaceuticals Announces Second Part of Phase 3 ANNEXA(TM)-R Study: Andexanet Alfa and Rivaroxaban Meets Primary and Secondary Endpoints September 16, 2015